XENOPORT INC Development Agreements
14 Contracts & Agreements
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on April 13, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
- our access to information related to the parent drugs of our product candidates may not reduce the risks and time associated with drug development (Filed With SEC on March 2, 2005)
